Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019

SELL
$8.57 - $10.72 $24,844 - $31,077
-2,899 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$7.58 - $10.0 $15,296 - $20,180
-2,018 Reduced 41.04%
2,899 $24,000
Q1 2019

Apr 29, 2019

BUY
$5.81 - $9.37 $11,137 - $17,962
1,917 Added 63.9%
4,917 $38,000
Q4 2018

Jan 28, 2019

BUY
$5.75 - $21.85 $17,250 - $65,550
3,000 New
3,000 $19,000

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $141M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.